Here is the top of page

This is the navigation link for moving toward in this page.

Go to main contents
Go to footer contents

A member of the Kyowa Kirin Group

Home
About Us
Mission

About Us

Print

Text size: view with small font size; view with medium font size; view with large font size

Mission

Therapeutic Antibody Technologies Out-Licensing
- POTELLIGENT^® Technology for ADCC-enhancement of therapeutic antibodies
- COMPLEGENT ^® Technology for CDC-enhancement of therapeutic antibodies
- AccretaMab ^® (Combination of POTELLIGENT ^® and COMPLEGENT ^® )

About Us